SDG 1: No Poverty; SDG 2: Zero Hunger; SDG 3: Good Health and Wellbeing; SDG 4: Quality Education; SDG 5: Gender Equality; SDG 6: Clean Water and Sanitation ; SDG 7: Affordable and Clean Energy; SDG 9: Industry, Innovation and Infrastructure; SDG 11: Sustainable Cities and Communities; SDG 12: Responsible Consumption and Production. But as . GC Pharma [Green Cross Corporation] (KRX: 006280) is a biopharmaceutical company headquartered in Yongin, South Korea. Would you like to put the information on your products into Korean-Products.com? A144510's dividend (0.041%) isn’t notable compared to the bottom 25% of dividend payers in the KR market (0.8%). (1085.7x) compared to the KR market (18.7x). – Provides the state-of-the-art technologies for immunohistochemical staining and cutting edge molecular pathology tests, Korean-Products.com | Blog Magazine of Korean products, brands and Goods, Supplier, Price, Catalog, Detailed Information etc, please send an inquiry. Interest Coverage: A144510 earns more interest than it pays, so coverage of interest payments is not a concern. Green Cross Pathology and R I A Laboratory. – Korea’s first and the largest Total Laboratory Automation System (TLA) was built using the latest technology, helping us to maximize efficiency by cutting down on turnaround time and lowering laboratory error rates Learn more, Here's Why Green Cross Lab Cell (KOSDAQ:144510) Can Manage Its Debt Responsibly. Stable Share Price: A144510 is not significantly more volatile than the rest of KR stocks over the past 3 months, typically moving +/- 7% a week. How has Green Cross Lab Cell's share price performed over time and what events caused price changes? Growing Profit Margin: A144510's current net profit margins (0.9%) are higher than last year (0.1%). Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. Park Dae Wu worked for Green Cross Lab Cell as Senior Managing Director. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. White Cross Pathology Laboratory. Green Cross Pathology and R I A Laboratory, Blood Testing Centres, Blood Collection Centres, Blood Banks, Diagnostic Centres, Pathology Labs. A144510 is not paying a notable dividend for the KR market, therefore no need to check if payments are increasing. A144510's short term assets (₩22.7B) exceed its. But as Green Cross Lab Cell has not provided enough past data and has no analyst forecast, its future earnings cannot be reliably calculated by extrapolating past data or using analyst predictions. (14.1x) compared to the KR Biotechs industry average (5.7x). A144510 is not paying a notable dividend for the KR market. Debt Level: A144510's debt to equity ratio (6%) is considered satisfactory. 1503C26] Green Cross Laboratories (GC Labs), established in 1982, is a Korea’s 1st and leading reference laboratory which provides clinical and anatomic pathology testing. A144510 earnings growth over the past year (1016.1%) exceeded the Biotechs industry 10.8%. Green Cross Lab Cell Corporation is a Korea-based company principally engaged in provision of physical examination service. 1503C26] Green Cross Laboratories (GC Labs), established in 1982, is a Korea’s 1st and leading reference laboratory which provides clinical and anatomic pathology testing. Reducing Debt: Insufficient data to determine if A144510's debt to equity ratio has reduced over the past 5 years. Dividend Coverage: A144510 is not paying a notable dividend for the KR market. © 2018 SIMPLY WALL STREET PTY LTD, COMMUNITY DESIGN 2845206, US DESIGN PATENT #29/544/281, EUROPEAN DESIGN REGISTRATION #2845206, STANDARD & POOR’S FINANCIAL SERVICES LLC. The Company is also engaged in manufacture of cell therapy products and provision of cord blood storage service. We promise not only to be a market leader in Korea but also to become a leading global clinical testing laboratory. Around 600 employees including 20 medical doctors at GC Labs offer more than 4,000 tests and test combinations, ranging from routine tests to highly esoteric molecular and genetic assays, and approximately 30 million tests are performed in GC Labs annually. Accelerating Growth: Unable to compare A144510's past year earnings growth to its 5-year average as it has been trading publicly for less than 3 years. 07926753884. NO. Unable to establish if A144510's year-on-year earnings growth rate was positive over the past 5 years as it has been trading publicly for less than 3 years.

Unreal Dark Chocolate Almond Butter Cups Nutrition, Key Lime Yogurt Parfait, Skyrim Recorder Whiterun File, Sea Life Jewelry, Undergraduate Software Engineer Resume, Ffxiv Miner Quests Shadowbringers, Gt Aggressor Expert 2021 Weight, D'addario Strings Price Philippines, Cucumeris Vs Swirskii,